- Any patient with structural heart disease, cardiomyopathy or known arrhythmias, or taking any medications known to prolong the QT interval, such as fluoroquinolones, Class IA (quinidine, procainamide) or Class III (dofetilide, amiodarone, sotalol) antiarrhythmic agents